Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$0.68 - $1.54 $5,637 - $12,768
-8,291 Reduced 99.99%
1 $0
Q2 2023

Aug 09, 2023

BUY
$1.19 - $1.79 $9,867 - $14,842
8,292 New
8,292 $11,000
Q3 2022

Nov 09, 2022

SELL
$0.08 - $22.6 $8 - $2,260
-100 Reduced 25.0%
300 $0
Q2 2022

Aug 11, 2022

BUY
$1.73 - $3.86 $692 - $1,544
400 New
400 $1,000

Others Institutions Holding JSPR

# of Institutions
1
Shares Held
5.63M
Call Options Held
0
Put Options Held
0

About Jasper Therapeutics, Inc.


  • Ticker JSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,073,300
  • Market Cap $806M
  • Description
  • Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...
More about JSPR
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.